Figure 5
From: Generation and characterization of human insulin-releasing cell lines
Susceptibility to cell death induction. APM, VGA and CPR cells were treated with increased doses of Doxorubicin (0.75–12 μM) (A) or were incubated in serum free medium for 96 h (B). Cell viability was determined using the MTS assay. The results are representative of three independent experiments. Each value represents the mean ± SD of triplicate determinations. a p < 0.001. ANOVA/Bonferroni's tests.